JPH10513355A - ヒトケモカインβ−１１およびヒトケモカインα−１ - Google Patents

ヒトケモカインβ−１１およびヒトケモカインα−１

Info

Publication number
JPH10513355A
JPH10513355A JP8524230A JP52423096A JPH10513355A JP H10513355 A JPH10513355 A JP H10513355A JP 8524230 A JP8524230 A JP 8524230A JP 52423096 A JP52423096 A JP 52423096A JP H10513355 A JPH10513355 A JP H10513355A
Authority
JP
Japan
Prior art keywords
polypeptide
polynucleotide
dna
sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP8524230A
Other languages
English (en)
Japanese (ja)
Inventor
リー，ハオドン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JPH10513355A publication Critical patent/JPH10513355A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP8524230A 1995-02-08 1995-02-08 ヒトケモカインβ−１１およびヒトケモカインα−１ Ceased JPH10513355A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/001780 WO1996024668A1 (fr) 1995-02-08 1995-02-08 Chemokine humaine beta-11 et chemokine humaine alpha-1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2002032255A Division JP2002320492A (ja) 2002-02-08 2002-02-08 ヒトケモカインβ−１１およびヒトケモカインα−１

Publications (1)

Publication Number Publication Date
JPH10513355A true JPH10513355A (ja) 1998-12-22

Family

ID=22248655

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8524230A Ceased JPH10513355A (ja) 1995-02-08 1995-02-08 ヒトケモカインβ−１１およびヒトケモカインα−１

Country Status (4)

Country Link
EP (1) EP0811059A4 (fr)
JP (1) JPH10513355A (fr)
AU (1) AU1916795A (fr)
WO (1) WO1996024668A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633149A (en) * 1994-12-07 1997-05-27 Incyte Pharmaceuticals, Inc. Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
CN1190991A (zh) * 1995-06-05 1998-08-19 人类基因组科学公司 人类趋化因子β－11和人类趋化因子α－1
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
NZ332318A (en) * 1996-03-19 2000-10-27 Human Genome Sciences Inc Chemokine alpha 2 and it's therapeutic and diagnostic use in treating illnesses
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
JP2000514295A (ja) * 1996-07-05 2000-10-31 シェーリング コーポレイション 哺乳動物のケモカイン試薬
US6723520B2 (en) 1996-07-05 2004-04-20 Schering Corporation Antibodies that bind chemokine teck
AU4243097A (en) * 1996-09-10 1998-04-02 Schering Corporation Mammalian chemokines, related reagents
WO1998011138A1 (fr) * 1996-09-12 1998-03-19 Human Genome Sciences, Inc. Chimiokine alpha-4
US6576445B1 (en) 1996-09-12 2003-06-10 Human Genome Sciences, Inc. Chemokine α-4
CA2267131A1 (fr) * 1996-10-04 1998-04-09 Human Genome Sciences, Inc. Compositions et procedes therapeutiques de traitement d'etats pathologiques par inhibiteur d'adhesion leucocytaire-1 (lai-1) et par chemokine beta-11 (ck.beta.-11)
AU5410698A (en) * 1996-12-13 1998-07-03 Shionogi & Co., Ltd. Human cc chemokine elc
EP1047775A1 (fr) * 1997-01-16 2000-11-02 Human Genome Sciences Facteur de signalisation hematopoietique
US6110695A (en) * 1997-12-02 2000-08-29 The Regents Of The University Of California Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
US20080199481A1 (en) 2007-02-21 2008-08-21 Astrazeneca Ab Compounds
JP5996429B2 (ja) 2009-09-03 2016-09-21 ジェネンテック， インコーポレイテッド 関節リウマチの治療、診断及びモニターするための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof
US5633149A (en) * 1994-12-07 1997-05-27 Incyte Pharmaceuticals, Inc. Polynucleotide encoding novel chemokine expressed in inflamed adenoid
US5605817A (en) * 1995-01-19 1997-02-25 Incyte Pharmaceuticals, Inc. DNA encoding chemokine expressed in fetal spleen
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides

Also Published As

Publication number Publication date
EP0811059A1 (fr) 1997-12-10
EP0811059A4 (fr) 1998-04-01
AU1916795A (en) 1996-08-27
WO1996024668A1 (fr) 1996-08-15

Similar Documents

Publication Publication Date Title
JPH10508742A (ja) ヒトケモカインポリペプチド
US7183081B2 (en) Human Ckβ-10 polynucleotides
JPH11507224A (ja) ヒトケモカインβ−１１およびヒトケモカインα−１
JPH11505417A (ja) ヒトケモカインベータ−８、ケモカインベータ−１、およびマクロファージ炎症性タンパク質−４
AU713267B2 (en) Human chemokine beta-13
JPH10510719A (ja) ヒトｇタンパク質ケモカインレセプターｈｄｇｎｒ１０
US7198944B2 (en) Human chemokine β-9 viral vectors
JPH10513355A (ja) ヒトケモカインβ−１１およびヒトケモカインα−１
JP3774230B2 (ja) ケラチノサイト増殖因子−２
MXPA97001330A (en) Chemistry beta-9 hum
JP2000507101A (ja) ケモカインアルファ２
US7045301B2 (en) Endothelial-monocyte activating polypeptide III antibodies
US5981230A (en) Polynucleotide encoding chemokine β-4
JP2001524818A (ja) ケモカインβ−６
JPH11507237A (ja) 単球走化性蛋白質−４
AU753730B2 (en) Human chemokine beta-13
AU750982B2 (en) Human chemokine beta-11 and human chemokine alpha-1
US7393943B1 (en) Polynucleotides encoding a human chemotactic cytokine I
JPH10512749A (ja) ヒトデオキシシチジンキナーゼ２
JP2001517073A (ja) ヒトケモカインポリペプチド
JP2002136294A (ja) ヒトケモカインポリペプチド
JP2003093076A (ja) ヒトケモカインβ−１３
JPH11510368A (ja) ヒトケモカインβ−１３
JP2002320492A (ja) ヒトケモカインβ−１１およびヒトケモカインα−１
KR19990087164A (ko) 사람 케모킨 폴리펩티드

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20031219

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20040205

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040309

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20040629

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20040720

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20040720

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20040824